Work

Androgen deprivation drives prostate cancer cells into a glycolysis-coupled senescence-like state

Year: 2026
Type: article
Abstract: The cellular origin, clinical significance, and metabolic features of the senescence-associated secretory phenotype (SASP) in prostate cancer remain poorly resolved. We integrated bulk transcriptomes from TCGA-PRAD (primary, n = 495) and SU2C (mCRPC, n = 208), two single-cell RNA-sequencing datasets, seven Visium sections, and one Xenium prostate adenocarcinoma section, together with immunoblotting in LNCaP and castration-adapted C4-2 cells treated with charcoal-stripped serum (CSS), enzalutamide (ENZ), and dihydrotestosterone (DHT). SASP formed a smooth, continuous gradient across bulk tumors rather than discrete subtypes. In Xenium, 4,657 of 25,517 tumor cells (18.3%) were positive for a senescence surrogate driven predominantly by p21 (CDKN1A) transcript detection; the local fraction of these cells correlated with a bin-level matrix-remodeling SASP program and glycolysis, but not with inflammatory SASP. The single-cell atlas revealed expansion of AR-low, stasis/senescence-like states in advanced disease. Within the adenocarcinoma compartment of one CRPC section, senescence-like hotspots showed higher glycolysis scores without a concomitant rise in proliferation. In vitro, CSS and ENZ increased p21/p16 and glycolytic proteins (GLUT1, LDHA, HK2), and treatment with 2-deoxy-D-glucose (2-DG) or the LDHA inhibitor FX-11 was associated with lower p21/p16 abundance. Androgen deprivation is associated with a prostate cancer senescence-like state and a glycolysis-related program; LDHA is a candidate metabolic node for further investigation; the present data do not establish therapeutic selectivity or efficacy. These spatial associations do not establish the cellular source of the SASP-related transcripts or paracrine signaling.
Language: English
Subfield: Cancer Research
Open Access status: gold
Estimated APC paid: $3,390
OpenAlex ID: W7236432276
FWCI:
Cites: 33
Cited by:
Related to: 10